This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04623/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04623/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB04623/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04623/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04623
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB04623 n11:DB04623
dcterms:title
2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE
adms:identifier
n6:46509051 n7:AKC n8:5459358 n12:DB04623
n3:IUPAC-Name
n4:271B4430-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4436-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4435-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4432-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4433-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4434-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B442E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B442C-363D-11E5-9242-09173F13E4C5 n4:271B442F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B442D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B443C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B443D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4437-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4438-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B443A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4439-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B443B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4442-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4444-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4445-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4441-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4440-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4443-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4431-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B443E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B443F-363D-11E5-9242-09173F13E4C5